Surface Oncology Receives $35,000,000 Series A Round

  • Feed Type
  • Date
    1/9/2015
  • Company Name
    Surface Oncology
  • Mailing Address
    Undisclosed Cambridge, MA 02139 USA
  • Company Description
    Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $35,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor
  • Venture Investor

Trending on Xconomy